Allakos Shares Dive 61% Following Pivot from Lirentelimab After Trial Results

By Denny Jacob Allakos shares dived 61% to $1.17 in premarket trading following news that it will halt lirentelimab-related activities across clinical,...

Related Keywords

Craig Paterson ,Denny Jacob , ,Chief Medical Officer Craig ,Article Normal ,Financial Performance ,Share Price Movement Disruptions ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Us01671p1003 ,Tallk ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,